

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.92570124 |
| 2 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.87736133 |
| 3 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.87494169 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 4.82144791 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.82144791 |
| 6 | cardiac muscle contraction (GO:0060048) | 4.74883673 |
| 7 | myofibril assembly (GO:0030239) | 4.66490331 |
| 8 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.50182576 |
| 9 | cardiac myofibril assembly (GO:0055003) | 4.42877168 |
| 10 | striated muscle contraction (GO:0006941) | 4.41452892 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 4.36561799 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.36561799 |
| 13 | creatine metabolic process (GO:0006600) | 4.35719253 |
| 14 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.24119033 |
| 15 | detection of calcium ion (GO:0005513) | 4.05134342 |
| 16 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.84921726 |
| 17 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.77459552 |
| 18 | cell communication by electrical coupling (GO:0010644) | 3.75877461 |
| 19 | cardiac muscle hypertrophy (GO:0003300) | 3.73572352 |
| 20 | cell communication involved in cardiac conduction (GO:0086065) | 3.72451708 |
| 21 | aromatic amino acid family catabolic process (GO:0009074) | 3.70028842 |
| 22 | striated muscle hypertrophy (GO:0014897) | 3.68486419 |
| 23 | actin filament-based movement (GO:0030048) | 3.60672349 |
| 24 | regulation of membrane repolarization (GO:0060306) | 3.60517331 |
| 25 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.60284263 |
| 26 | aspartate family amino acid catabolic process (GO:0009068) | 3.58073547 |
| 27 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.54933850 |
| 28 | cellular potassium ion homeostasis (GO:0030007) | 3.51810823 |
| 29 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.51509564 |
| 30 | actomyosin structure organization (GO:0031032) | 3.48590852 |
| 31 | relaxation of cardiac muscle (GO:0055119) | 3.45586650 |
| 32 | regulation of striated muscle contraction (GO:0006942) | 3.44952101 |
| 33 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.44190854 |
| 34 | valine metabolic process (GO:0006573) | 3.40090870 |
| 35 | carnitine shuttle (GO:0006853) | 3.36563520 |
| 36 | fatty acid elongation (GO:0030497) | 3.35914383 |
| 37 | cerebellar granule cell differentiation (GO:0021707) | 3.31402039 |
| 38 | branched-chain amino acid catabolic process (GO:0009083) | 3.29538629 |
| 39 | fatty acid transmembrane transport (GO:1902001) | 3.29371034 |
| 40 | lysine metabolic process (GO:0006553) | 3.28874857 |
| 41 | lysine catabolic process (GO:0006554) | 3.28874857 |
| 42 | short-chain fatty acid metabolic process (GO:0046459) | 3.28857861 |
| 43 | muscle hypertrophy (GO:0014896) | 3.24973596 |
| 44 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.24353671 |
| 45 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.22893142 |
| 46 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.22893142 |
| 47 | central nervous system myelination (GO:0022010) | 3.22656564 |
| 48 | axon ensheathment in central nervous system (GO:0032291) | 3.22656564 |
| 49 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.22472714 |
| 50 | sodium ion export (GO:0071436) | 3.20826337 |
| 51 | cysteine metabolic process (GO:0006534) | 3.20535968 |
| 52 | response to inactivity (GO:0014854) | 3.20083942 |
| 53 | branched-chain amino acid metabolic process (GO:0009081) | 3.16101456 |
| 54 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.13256701 |
| 55 | coenzyme catabolic process (GO:0009109) | 3.12493185 |
| 56 | fatty acid catabolic process (GO:0009062) | 3.10555983 |
| 57 | fatty acid beta-oxidation (GO:0006635) | 3.10155344 |
| 58 | regulation of relaxation of muscle (GO:1901077) | 3.07179605 |
| 59 | NADH metabolic process (GO:0006734) | 3.07123954 |
| 60 | acetyl-CoA metabolic process (GO:0006084) | 3.06981037 |
| 61 | muscle contraction (GO:0006936) | 3.06180168 |
| 62 | response to mercury ion (GO:0046689) | 3.05076700 |
| 63 | glyoxylate metabolic process (GO:0046487) | 3.04527404 |
| 64 | carnitine transmembrane transport (GO:1902603) | 3.04135179 |
| 65 | amino-acid betaine transport (GO:0015838) | 3.02125447 |
| 66 | carnitine transport (GO:0015879) | 3.02125447 |
| 67 | muscle filament sliding (GO:0030049) | 3.01751544 |
| 68 | actin-myosin filament sliding (GO:0033275) | 3.01751544 |
| 69 | cellular ketone body metabolic process (GO:0046950) | 2.99677875 |
| 70 | relaxation of muscle (GO:0090075) | 2.97047673 |
| 71 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.96752421 |
| 72 | regulation of cell communication by electrical coupling (GO:0010649) | 2.96658067 |
| 73 | drug transmembrane transport (GO:0006855) | 2.95493567 |
| 74 | fatty acid oxidation (GO:0019395) | 2.95189241 |
| 75 | cellular sodium ion homeostasis (GO:0006883) | 2.91768739 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 2.88931488 |
| 77 | positive regulation of synapse maturation (GO:0090129) | 2.88742098 |
| 78 | lipid oxidation (GO:0034440) | 2.88488239 |
| 79 | cardiac conduction (GO:0061337) | 2.88245794 |
| 80 | synaptic vesicle exocytosis (GO:0016079) | 2.87807849 |
| 81 | positive regulation of cation channel activity (GO:2001259) | 2.87305268 |
| 82 | monocarboxylic acid catabolic process (GO:0072329) | 2.86600315 |
| 83 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.86212048 |
| 84 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.85896253 |
| 85 | regulation of heart rate (GO:0002027) | 2.84763334 |
| 86 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.84753345 |
| 87 | regulation of triglyceride catabolic process (GO:0010896) | 2.82881933 |
| 88 | cardiac muscle cell action potential (GO:0086001) | 2.82734317 |
| 89 | kynurenine metabolic process (GO:0070189) | 2.82713825 |
| 90 | sarcomere organization (GO:0045214) | 2.82404375 |
| 91 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.82266018 |
| 92 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.81698517 |
| 93 | intestinal cholesterol absorption (GO:0030299) | 2.81308955 |
| 94 | regulation of skeletal muscle contraction (GO:0014819) | 2.79760800 |
| 95 | muscle system process (GO:0003012) | 2.79496244 |
| 96 | response to epinephrine (GO:0071871) | 2.78612475 |
| 97 | potassium ion import (GO:0010107) | 2.78570753 |
| 98 | quaternary ammonium group transport (GO:0015697) | 2.78570266 |
| 99 | regulation of the force of heart contraction (GO:0002026) | 2.77687094 |
| 100 | tryptophan catabolic process (GO:0006569) | 2.77468849 |
| 101 | indole-containing compound catabolic process (GO:0042436) | 2.77468849 |
| 102 | indolalkylamine catabolic process (GO:0046218) | 2.77468849 |
| 103 | bile acid biosynthetic process (GO:0006699) | 2.77230313 |
| 104 | regulation of cardiac muscle contraction (GO:0055117) | 2.76414301 |
| 105 | muscle tissue morphogenesis (GO:0060415) | 2.75791291 |
| 106 | positive regulation of sodium ion transport (GO:0010765) | 2.73848114 |
| 107 | regulation of sodium ion transmembrane transport (GO:1902305) | 2.73152305 |
| 108 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.73141227 |
| 109 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.73141227 |
| 110 | neuronal action potential propagation (GO:0019227) | 2.72891919 |
| 111 | positive regulation of potassium ion transport (GO:0043268) | 2.72427215 |
| 112 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.72390239 |
| 113 | cellular response to epinephrine stimulus (GO:0071872) | 2.72271794 |
| 114 | striated muscle adaptation (GO:0014888) | 2.71067394 |
| 115 | amino-acid betaine metabolic process (GO:0006577) | 2.70492485 |
| 116 | cellular glucuronidation (GO:0052695) | 2.70031767 |
| 117 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.67289238 |
| 118 | very long-chain fatty acid metabolic process (GO:0000038) | 2.66285211 |
| 119 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.65859686 |
| 120 | alpha-linolenic acid metabolic process (GO:0036109) | 2.65587135 |
| 121 | membrane depolarization during action potential (GO:0086010) | 2.65524241 |
| 122 | acyl-CoA biosynthetic process (GO:0071616) | 2.65388569 |
| 123 | thioester biosynthetic process (GO:0035384) | 2.65388569 |
| 124 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.65208226 |
| 125 | skeletal muscle contraction (GO:0003009) | 2.62717467 |
| 126 | uronic acid metabolic process (GO:0006063) | 2.62395556 |
| 127 | glucuronate metabolic process (GO:0019585) | 2.62395556 |
| 128 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.61899915 |
| 129 | muscle hypertrophy in response to stress (GO:0003299) | 2.61899915 |
| 130 | cardiac muscle adaptation (GO:0014887) | 2.61899915 |
| 131 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.61666896 |
| 132 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.60733580 |
| 133 | carnitine metabolic process (GO:0009437) | 2.60676453 |
| 134 | tryptophan metabolic process (GO:0006568) | 2.60189186 |
| 135 | regulation of actin filament-based movement (GO:1903115) | 2.59767840 |
| 136 | ketone body metabolic process (GO:1902224) | 2.58867854 |
| 137 | alpha-amino acid catabolic process (GO:1901606) | 2.58699496 |
| 138 | acyl-CoA metabolic process (GO:0006637) | 2.58598598 |
| 139 | thioester metabolic process (GO:0035383) | 2.58598598 |
| 140 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.58598221 |
| 141 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 2.56581722 |
| 142 | heart contraction (GO:0060047) | 2.55593700 |
| 143 | heart process (GO:0003015) | 2.55593700 |
| 144 | actin-mediated cell contraction (GO:0070252) | 2.55413609 |
| 145 | regulation of heart contraction (GO:0008016) | 2.55194804 |
| 146 | regulation of cation channel activity (GO:2001257) | 2.54148858 |
| 147 | macroautophagy (GO:0016236) | 2.53549417 |
| 148 | cofactor catabolic process (GO:0051187) | 2.53512633 |
| 149 | aromatic amino acid family metabolic process (GO:0009072) | 2.52297638 |
| 150 | carboxylic acid catabolic process (GO:0046395) | 2.51473764 |
| 151 | organic acid catabolic process (GO:0016054) | 2.51473764 |
| 152 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.50633192 |
| 153 | regulation of sequestering of triglyceride (GO:0010889) | 2.50418310 |
| 154 | ethanol oxidation (GO:0006069) | 2.49840492 |
| 155 | cellular amino acid catabolic process (GO:0009063) | 2.49610291 |
| 156 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.46743641 |
| 157 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.46190827 |
| 158 | cellular modified amino acid catabolic process (GO:0042219) | 2.44078132 |
| 159 | succinate metabolic process (GO:0006105) | 2.43881997 |
| 160 | sulfur amino acid catabolic process (GO:0000098) | 2.42848726 |
| 161 | glutamate metabolic process (GO:0006536) | 2.39942483 |
| 162 | dicarboxylic acid catabolic process (GO:0043649) | 2.39810438 |
| 163 | myelin maintenance (GO:0043217) | 2.39430348 |
| 164 | regulation of cholesterol metabolic process (GO:0090181) | 2.38777691 |
| 165 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.37756385 |
| 166 | tricarboxylic acid cycle (GO:0006099) | 2.35467177 |
| 167 | skeletal muscle adaptation (GO:0043501) | 2.34993040 |
| 168 | tyrosine metabolic process (GO:0006570) | 2.34013814 |
| 169 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.33437718 |
| 170 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.32526430 |
| 171 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.31390654 |
| 172 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.30824564 |
| 173 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.30372426 |
| 174 | alkaloid metabolic process (GO:0009820) | 2.30355795 |
| 175 | negative regulation of protein localization to cell surface (GO:2000009) | 2.29273300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.30328050 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.82509385 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.09344842 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.75216397 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.58644612 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.49551125 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.38982001 |
| 8 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.38708366 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.08608121 |
| 10 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.98273677 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.97132112 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.92156511 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.89465434 |
| 14 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.84169776 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.72909046 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 1.71905033 |
| 17 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71331066 |
| 18 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70821357 |
| 19 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.69897447 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.69558254 |
| 21 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.68952732 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.67329285 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.67329285 |
| 24 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.64785646 |
| 25 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.62325526 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.61153194 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.61133733 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.59700248 |
| 29 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.53352142 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.51481942 |
| 31 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.51419630 |
| 32 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.49997776 |
| 33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44803010 |
| 34 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.44376998 |
| 35 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44018859 |
| 36 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43514353 |
| 37 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.41064059 |
| 38 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.39725411 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.39556777 |
| 40 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.38227339 |
| 41 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36335434 |
| 42 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35954177 |
| 43 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.34400248 |
| 44 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.33779332 |
| 45 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.33779332 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.32981248 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32104466 |
| 48 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26083673 |
| 49 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.23239150 |
| 50 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.22613931 |
| 51 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.22452016 |
| 52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.21511162 |
| 53 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.20016116 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19544531 |
| 55 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.18849579 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.17259238 |
| 57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16358232 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16139001 |
| 59 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.16092070 |
| 60 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.15615787 |
| 61 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.15615787 |
| 62 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.14827710 |
| 63 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14748030 |
| 64 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13476645 |
| 65 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12973464 |
| 66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.12661618 |
| 67 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11738209 |
| 68 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11049706 |
| 69 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.10821372 |
| 70 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.10795903 |
| 71 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10650552 |
| 72 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10455898 |
| 73 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.09348114 |
| 74 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.08698854 |
| 75 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.08463007 |
| 76 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.08460160 |
| 77 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08067871 |
| 78 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.07986584 |
| 79 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.07521733 |
| 80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.07071089 |
| 81 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.06352941 |
| 82 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.05401524 |
| 83 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.04956976 |
| 84 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.04539069 |
| 85 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04113790 |
| 86 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03997424 |
| 87 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.03623472 |
| 88 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.02704473 |
| 89 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.02691816 |
| 90 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.00833330 |
| 91 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.00242391 |
| 92 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99035143 |
| 93 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98194965 |
| 94 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97812589 |
| 95 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.97569024 |
| 96 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.97425873 |
| 97 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97068776 |
| 98 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96979871 |
| 99 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96786202 |
| 100 | AR_19668381_ChIP-Seq_PC3_Human | 0.96561178 |
| 101 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.96370577 |
| 102 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.95521187 |
| 103 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95450013 |
| 104 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.95296545 |
| 105 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94708547 |
| 106 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94045158 |
| 107 | GATA2_19941826_ChIP-Seq_K562_Human | 0.93559106 |
| 108 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92709266 |
| 109 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92494177 |
| 110 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.91676288 |
| 111 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91470802 |
| 112 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.91374585 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91186266 |
| 114 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.90939233 |
| 115 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.90126463 |
| 116 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89799116 |
| 117 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.89703124 |
| 118 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.89473659 |
| 119 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.89284674 |
| 120 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89260807 |
| 121 | VDR_22108803_ChIP-Seq_LS180_Human | 0.88399325 |
| 122 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87983867 |
| 123 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.87849506 |
| 124 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.87192284 |
| 125 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.86898863 |
| 126 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86224051 |
| 127 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.85510903 |
| 128 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85507495 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85373403 |
| 130 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.85150011 |
| 131 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.85068114 |
| 132 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84971920 |
| 133 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.84446575 |
| 134 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.84446575 |
| 135 | P300_19829295_ChIP-Seq_ESCs_Human | 0.84090004 |
| 136 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.83670432 |
| 137 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83292107 |
| 138 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83139768 |
| 139 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81986757 |
| 140 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.81909446 |
| 141 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.81804113 |
| 142 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81559431 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80216027 |
| 144 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.79219264 |
| 145 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.79093341 |
| 146 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.78971401 |
| 147 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.78760309 |
| 148 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.78430152 |
| 149 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78326687 |
| 150 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77857772 |
| 151 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.77810793 |
| 152 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.77771977 |
| 153 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.76968842 |
| 154 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.76755522 |
| 155 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.75844545 |
| 156 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.74011177 |
| 157 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.73914906 |
| 158 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.73658893 |
| 159 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.73331527 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.84947481 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 3.65897167 |
| 3 | MP0005360_urolithiasis | 3.38479263 |
| 4 | MP0005365_abnormal_bile_salt | 3.31350290 |
| 5 | MP0005083_abnormal_biliary_tract | 3.12213528 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 2.86872711 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.69919530 |
| 8 | MP0001666_abnormal_nutrient_absorption | 2.63049910 |
| 9 | MP0000751_myopathy | 2.50190260 |
| 10 | MP0003195_calcinosis | 2.48072246 |
| 11 | MP0000749_muscle_degeneration | 2.46445542 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.46163290 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.43052442 |
| 14 | MP0003646_muscle_fatigue | 2.33733128 |
| 15 | MP0004036_abnormal_muscle_relaxation | 2.29552865 |
| 16 | MP0004130_abnormal_muscle_cell | 2.24723032 |
| 17 | MP0000920_abnormal_myelination | 2.11204490 |
| 18 | MP0005332_abnormal_amino_acid | 2.04315897 |
| 19 | MP0003879_abnormal_hair_cell | 1.97213874 |
| 20 | MP0003252_abnormal_bile_duct | 1.93721840 |
| 21 | MP0004084_abnormal_cardiac_muscle | 1.85724569 |
| 22 | MP0002272_abnormal_nervous_system | 1.81830254 |
| 23 | MP0002064_seizures | 1.80931891 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 1.80578769 |
| 25 | MP0000747_muscle_weakness | 1.76806333 |
| 26 | MP0003635_abnormal_synaptic_transmissio | 1.74651907 |
| 27 | MP0009780_abnormal_chondrocyte_physiolo | 1.70075629 |
| 28 | MP0006138_congestive_heart_failure | 1.69842569 |
| 29 | MP0005670_abnormal_white_adipose | 1.68428606 |
| 30 | MP0009745_abnormal_behavioral_response | 1.64086888 |
| 31 | MP0005330_cardiomyopathy | 1.64028266 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.61678433 |
| 33 | MP0009046_muscle_twitch | 1.59630850 |
| 34 | MP0008569_lethality_at_weaning | 1.58983476 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57089801 |
| 36 | MP0005451_abnormal_body_composition | 1.55384501 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.53170523 |
| 38 | MP0004215_abnormal_myocardial_fiber | 1.52899977 |
| 39 | MP0001486_abnormal_startle_reflex | 1.49233897 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.48878631 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.47291086 |
| 42 | MP0001984_abnormal_olfaction | 1.45932253 |
| 43 | MP0001440_abnormal_grooming_behavior | 1.45114454 |
| 44 | MP0002106_abnormal_muscle_physiology | 1.45015913 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.44501975 |
| 46 | MP0004484_altered_response_of | 1.44329082 |
| 47 | MP0009840_abnormal_foam_cell | 1.44067430 |
| 48 | MP0004087_abnormal_muscle_fiber | 1.42170330 |
| 49 | MP0004145_abnormal_muscle_electrophysio | 1.39310575 |
| 50 | MP0002063_abnormal_learning/memory/cond | 1.37672515 |
| 51 | MP0004742_abnormal_vestibular_system | 1.36270333 |
| 52 | MP0003950_abnormal_plasma_membrane | 1.36227972 |
| 53 | MP0002972_abnormal_cardiac_muscle | 1.36225061 |
| 54 | MP0003656_abnormal_erythrocyte_physiolo | 1.35913024 |
| 55 | MP0005620_abnormal_muscle_contractility | 1.35719645 |
| 56 | MP0004885_abnormal_endolymph | 1.35545701 |
| 57 | MP0005423_abnormal_somatic_nervous | 1.34611724 |
| 58 | MP0002734_abnormal_mechanical_nocicepti | 1.34609843 |
| 59 | MP0003690_abnormal_glial_cell | 1.34443445 |
| 60 | MP0010329_abnormal_lipoprotein_level | 1.34434413 |
| 61 | MP0002127_abnormal_cardiovascular_syste | 1.27510369 |
| 62 | MP0002638_abnormal_pupillary_reflex | 1.25627380 |
| 63 | MP0002735_abnormal_chemical_nociception | 1.24809911 |
| 64 | MP0004924_abnormal_behavior | 1.24179190 |
| 65 | MP0005386_behavior/neurological_phenoty | 1.24179190 |
| 66 | MP0003868_abnormal_feces_composition | 1.20526977 |
| 67 | MP0002254_reproductive_system_inflammat | 1.20047961 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 1.18739210 |
| 69 | MP0001835_abnormal_antigen_presentation | 1.17475664 |
| 70 | MP0003880_abnormal_central_pattern | 1.16943031 |
| 71 | MP0004510_myositis | 1.16207368 |
| 72 | MP0004043_abnormal_pH_regulation | 1.15485005 |
| 73 | MP0009643_abnormal_urine_homeostasis | 1.13862254 |
| 74 | MP0002572_abnormal_emotion/affect_behav | 1.12229592 |
| 75 | MP0005369_muscle_phenotype | 1.11282709 |
| 76 | MP0006082_CNS_inflammation | 1.09194160 |
| 77 | MP0000013_abnormal_adipose_tissue | 1.06740518 |
| 78 | MP0003221_abnormal_cardiomyocyte_apopto | 1.05734674 |
| 79 | MP0002067_abnormal_sensory_capabilities | 1.05519224 |
| 80 | MP0005165_increased_susceptibility_to | 1.02100840 |
| 81 | MP0004233_abnormal_muscle_weight | 1.01382322 |
| 82 | MP0002269_muscular_atrophy | 0.99155897 |
| 83 | MP0005535_abnormal_body_temperature | 0.98665674 |
| 84 | MP0000343_altered_response_to | 0.97218514 |
| 85 | MP0005385_cardiovascular_system_phenoty | 0.97189865 |
| 86 | MP0001544_abnormal_cardiovascular_syste | 0.97189865 |
| 87 | MP0000609_abnormal_liver_physiology | 0.96995761 |
| 88 | MP0000604_amyloidosis | 0.96347861 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 0.95685146 |
| 90 | MP0008775_abnormal_heart_ventricle | 0.93789831 |
| 91 | MP0009764_decreased_sensitivity_to | 0.93110629 |
| 92 | MP0005464_abnormal_platelet_physiology | 0.92149525 |
| 93 | MP0010678_abnormal_skin_adnexa | 0.91129201 |
| 94 | MP0008469_abnormal_protein_level | 0.90976680 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.90483278 |
| 96 | MP0000685_abnormal_immune_system | 0.90386519 |
| 97 | MP0009785_altered_susceptibility_to | 0.90184568 |
| 98 | MP0003724_increased_susceptibility_to | 0.90056140 |
| 99 | MP0004147_increased_porphyrin_level | 0.89826192 |
| 100 | MP0010630_abnormal_cardiac_muscle | 0.89442053 |
| 101 | MP0000383_abnormal_hair_follicle | 0.89334446 |
| 102 | MP0000759_abnormal_skeletal_muscle | 0.88650262 |
| 103 | MP0001502_abnormal_circadian_rhythm | 0.88436013 |
| 104 | MP0003137_abnormal_impulse_conducting | 0.88109890 |
| 105 | MP0002148_abnormal_hypersensitivity_rea | 0.87689211 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.85925265 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 0.85421108 |
| 108 | MP0001485_abnormal_pinna_reflex | 0.85213458 |
| 109 | MP0001790_abnormal_immune_system | 0.84913298 |
| 110 | MP0005387_immune_system_phenotype | 0.84913298 |
| 111 | MP0008874_decreased_physiological_sensi | 0.84907322 |
| 112 | MP0002822_catalepsy | 0.84647662 |
| 113 | MP0001765_abnormal_ion_homeostasis | 0.84177040 |
| 114 | MP0005646_abnormal_pituitary_gland | 0.83783342 |
| 115 | MP0004270_analgesia | 0.83653827 |
| 116 | MP0002108_abnormal_muscle_morphology | 0.83500483 |
| 117 | MP0001764_abnormal_homeostasis | 0.82610971 |
| 118 | MP0002419_abnormal_innate_immunity | 0.82208841 |
| 119 | MP0003329_amyloid_beta_deposits | 0.81884776 |
| 120 | MP0009765_abnormal_xenobiotic_induced | 0.80617811 |
| 121 | MP0000230_abnormal_systemic_arterial | 0.80392176 |
| 122 | MP0005375_adipose_tissue_phenotype | 0.80343983 |
| 123 | MP0001873_stomach_inflammation | 0.79525327 |
| 124 | MP0000003_abnormal_adipose_tissue | 0.79327728 |
| 125 | MP0004019_abnormal_vitamin_homeostasis | 0.78215262 |
| 126 | MP0003186_abnormal_redox_activity | 0.78140057 |
| 127 | MP0002229_neurodegeneration | 0.77641591 |
| 128 | MP0003631_nervous_system_phenotype | 0.77464121 |
| 129 | MP0003436_decreased_susceptibility_to | 0.76347447 |
| 130 | MP0001970_abnormal_pain_threshold | 0.75485974 |
| 131 | MP0002876_abnormal_thyroid_physiology | 0.74331629 |
| 132 | MP0004381_abnormal_hair_follicle | 0.73683375 |
| 133 | MP0003300_gastrointestinal_ulcer | 0.73451071 |
| 134 | MP0005636_abnormal_mineral_homeostasis | 0.72967204 |
| 135 | MP0005025_abnormal_response_to | 0.72684162 |
| 136 | MP0005551_abnormal_eye_electrophysiolog | 0.72108836 |
| 137 | MP0002078_abnormal_glucose_homeostasis | 0.71729743 |
| 138 | MP0004142_abnormal_muscle_tone | 0.71712918 |
| 139 | MP0003045_fibrosis | 0.71555964 |
| 140 | MP0003633_abnormal_nervous_system | 0.71297233 |
| 141 | MP0009763_increased_sensitivity_to | 0.70134210 |
| 142 | MP0004085_abnormal_heartbeat | 0.69383065 |
| 143 | MP0002971_abnormal_brown_adipose | 0.68219775 |
| 144 | MP0000750_abnormal_muscle_regeneration | 0.67256355 |
| 145 | MP0001968_abnormal_touch/_nociception | 0.67029416 |
| 146 | MP0003638_abnormal_response/metabolism_ | 0.66395338 |
| 147 | MP0002909_abnormal_adrenal_gland | 0.66048729 |
| 148 | MP0003634_abnormal_glial_cell | 0.63748700 |
| 149 | MP0001299_abnormal_eye_distance/ | 0.63082626 |
| 150 | MP0000778_abnormal_nervous_system | 0.62621137 |
| 151 | MP0002882_abnormal_neuron_morphology | 0.61784756 |
| 152 | MP0003011_delayed_dark_adaptation | 0.61774031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bundle branch block (HP:0011710) | 5.82679729 |
| 2 | Exercise-induced myalgia (HP:0003738) | 4.23420091 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.01917220 |
| 4 | Heart block (HP:0012722) | 3.88349120 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 3.83218130 |
| 6 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.80375105 |
| 7 | Calf muscle hypertrophy (HP:0008981) | 3.68527837 |
| 8 | Hyporeflexia of lower limbs (HP:0002600) | 3.63290485 |
| 9 | Abnormal atrioventricular conduction (HP:0005150) | 3.55315395 |
| 10 | Muscle fiber inclusion bodies (HP:0100299) | 3.51474846 |
| 11 | Muscle fiber splitting (HP:0003555) | 3.49222042 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.41802995 |
| 13 | Frequent falls (HP:0002359) | 3.38382243 |
| 14 | Ventricular fibrillation (HP:0001663) | 3.36586904 |
| 15 | Ventricular arrhythmia (HP:0004308) | 3.22665867 |
| 16 | Sudden death (HP:0001699) | 3.20757345 |
| 17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.16797527 |
| 18 | Myoglobinuria (HP:0002913) | 3.14307921 |
| 19 | Nemaline bodies (HP:0003798) | 3.12150877 |
| 20 | Action tremor (HP:0002345) | 3.11183032 |
| 21 | Axonal loss (HP:0003447) | 3.07810532 |
| 22 | Focal motor seizures (HP:0011153) | 3.06248938 |
| 23 | Atrioventricular block (HP:0001678) | 3.02868280 |
| 24 | EMG: neuropathic changes (HP:0003445) | 3.01501121 |
| 25 | Intrahepatic cholestasis (HP:0001406) | 2.98494497 |
| 26 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.98240395 |
| 27 | Rimmed vacuoles (HP:0003805) | 2.93308245 |
| 28 | Ketosis (HP:0001946) | 2.89764616 |
| 29 | Febrile seizures (HP:0002373) | 2.84682112 |
| 30 | Hyperlipoproteinemia (HP:0010980) | 2.80016380 |
| 31 | Palpitations (HP:0001962) | 2.78516647 |
| 32 | EMG: myopathic abnormalities (HP:0003458) | 2.77712821 |
| 33 | Right ventricular cardiomyopathy (HP:0011663) | 2.74711518 |
| 34 | Xanthomatosis (HP:0000991) | 2.71997498 |
| 35 | Distal lower limb muscle weakness (HP:0009053) | 2.71493352 |
| 36 | Myopathic facies (HP:0002058) | 2.69914194 |
| 37 | Ventricular tachycardia (HP:0004756) | 2.69301712 |
| 38 | Hyperammonemia (HP:0001987) | 2.68555425 |
| 39 | Hyperkalemia (HP:0002153) | 2.64559251 |
| 40 | Abnormality of the calf musculature (HP:0001430) | 2.62303503 |
| 41 | Cerebral edema (HP:0002181) | 2.59376170 |
| 42 | Myokymia (HP:0002411) | 2.59174307 |
| 43 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.51953754 |
| 44 | Gout (HP:0001997) | 2.51876323 |
| 45 | Abnormality of the foot musculature (HP:0001436) | 2.50691168 |
| 46 | Deep venous thrombosis (HP:0002625) | 2.46374813 |
| 47 | Round ear (HP:0100830) | 2.45323750 |
| 48 | Increased variability in muscle fiber diameter (HP:0003557) | 2.44309483 |
| 49 | Fetal akinesia sequence (HP:0001989) | 2.44256701 |
| 50 | Ketoacidosis (HP:0001993) | 2.43936236 |
| 51 | Abnormal EKG (HP:0003115) | 2.43929224 |
| 52 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.41132562 |
| 53 | Generalized aminoaciduria (HP:0002909) | 2.39305303 |
| 54 | Atonic seizures (HP:0010819) | 2.37059926 |
| 55 | Asymmetric septal hypertrophy (HP:0001670) | 2.36680708 |
| 56 | Acute encephalopathy (HP:0006846) | 2.35652061 |
| 57 | Distal arthrogryposis (HP:0005684) | 2.35489653 |
| 58 | Focal seizures (HP:0007359) | 2.34623273 |
| 59 | Muscle stiffness (HP:0003552) | 2.32122849 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.31450479 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.31450479 |
| 62 | Areflexia of lower limbs (HP:0002522) | 2.31443518 |
| 63 | Difficulty running (HP:0009046) | 2.30614251 |
| 64 | Rhabdomyolysis (HP:0003201) | 2.28839636 |
| 65 | Atrial fibrillation (HP:0005110) | 2.26649599 |
| 66 | Left ventricular hypertrophy (HP:0001712) | 2.25363233 |
| 67 | Fat malabsorption (HP:0002630) | 2.21409698 |
| 68 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21257541 |
| 69 | Abnormality of glycine metabolism (HP:0010895) | 2.21257541 |
| 70 | Dysmetric saccades (HP:0000641) | 2.20286412 |
| 71 | Primary atrial arrhythmia (HP:0001692) | 2.20186025 |
| 72 | Syncope (HP:0001279) | 2.18844822 |
| 73 | Abnormality of methionine metabolism (HP:0010901) | 2.18821927 |
| 74 | Generalized muscle weakness (HP:0003324) | 2.18091018 |
| 75 | Cerebral hemorrhage (HP:0001342) | 2.18029981 |
| 76 | Increased connective tissue (HP:0009025) | 2.17245451 |
| 77 | Steatorrhea (HP:0002570) | 2.16932499 |
| 78 | Abnormality of purine metabolism (HP:0004352) | 2.16801935 |
| 79 | Metabolic acidosis (HP:0001942) | 2.15005555 |
| 80 | Acute necrotizing encephalopathy (HP:0006965) | 2.14450366 |
| 81 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.13429787 |
| 82 | Myotonia (HP:0002486) | 2.12359848 |
| 83 | Hypoglycemic coma (HP:0001325) | 2.12149031 |
| 84 | Prolonged partial thromboplastin time (HP:0003645) | 2.11386619 |
| 85 | Dysdiadochokinesis (HP:0002075) | 2.11124048 |
| 86 | Dilated cardiomyopathy (HP:0001644) | 2.10933563 |
| 87 | Hyperventilation (HP:0002883) | 2.10258110 |
| 88 | Neurofibrillary tangles (HP:0002185) | 2.07118299 |
| 89 | Increased purine levels (HP:0004368) | 2.04846169 |
| 90 | Hyperuricemia (HP:0002149) | 2.04846169 |
| 91 | Supraventricular tachycardia (HP:0004755) | 2.04518273 |
| 92 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.03838083 |
| 93 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.02221783 |
| 94 | Hepatic necrosis (HP:0002605) | 2.00991537 |
| 95 | Lipoatrophy (HP:0100578) | 1.99730780 |
| 96 | Complement deficiency (HP:0004431) | 1.99258868 |
| 97 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.98445589 |
| 98 | Absent phalangeal crease (HP:0006109) | 1.96816972 |
| 99 | Supraventricular arrhythmia (HP:0005115) | 1.96112836 |
| 100 | Hyperglycinuria (HP:0003108) | 1.94742362 |
| 101 | Hypoalphalipoproteinemia (HP:0003233) | 1.94693130 |
| 102 | Lethargy (HP:0001254) | 1.94384128 |
| 103 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.93993936 |
| 104 | Absence seizures (HP:0002121) | 1.93319397 |
| 105 | Vascular calcification (HP:0004934) | 1.92741793 |
| 106 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.91723374 |
| 107 | Subaortic stenosis (HP:0001682) | 1.91430523 |
| 108 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.91430523 |
| 109 | Hypothermia (HP:0002045) | 1.91212022 |
| 110 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.91206044 |
| 111 | Ankle clonus (HP:0011448) | 1.91133789 |
| 112 | Type 1 muscle fiber predominance (HP:0003803) | 1.90137488 |
| 113 | Gowers sign (HP:0003391) | 1.90025506 |
| 114 | Neck muscle weakness (HP:0000467) | 1.88684112 |
| 115 | Intention tremor (HP:0002080) | 1.88452241 |
| 116 | Foot dorsiflexor weakness (HP:0009027) | 1.88227813 |
| 117 | Progressive macrocephaly (HP:0004481) | 1.88053235 |
| 118 | Ulnar deviation of the wrist (HP:0003049) | 1.87528741 |
| 119 | Increased muscle lipid content (HP:0009058) | 1.85927370 |
| 120 | Bulbar palsy (HP:0001283) | 1.85665501 |
| 121 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.85150073 |
| 122 | Amyloidosis (HP:0011034) | 1.84702594 |
| 123 | Stridor (HP:0010307) | 1.83250979 |
| 124 | Vomiting (HP:0002013) | 1.82014491 |
| 125 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.81935838 |
| 126 | Amblyopia (HP:0000646) | 1.81896353 |
| 127 | Broad-based gait (HP:0002136) | 1.81359561 |
| 128 | Abnormality of urine glucose concentration (HP:0011016) | 1.81155089 |
| 129 | Glycosuria (HP:0003076) | 1.81155089 |
| 130 | Scapular winging (HP:0003691) | 1.80713182 |
| 131 | Onion bulb formation (HP:0003383) | 1.80671474 |
| 132 | Prolonged QT interval (HP:0001657) | 1.80612820 |
| 133 | Increased serum pyruvate (HP:0003542) | 1.80146803 |
| 134 | Abnormality of glycolysis (HP:0004366) | 1.80146803 |
| 135 | Generalized tonic-clonic seizures (HP:0002069) | 1.79518672 |
| 136 | Proximal tubulopathy (HP:0000114) | 1.78910093 |
| 137 | Cholelithiasis (HP:0001081) | 1.78528995 |
| 138 | Abnormal gallbladder morphology (HP:0012437) | 1.77835789 |
| 139 | Hyperglycinemia (HP:0002154) | 1.77757797 |
| 140 | Sudden cardiac death (HP:0001645) | 1.76800840 |
| 141 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.76664931 |
| 142 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.76664931 |
| 143 | Nonprogressive disorder (HP:0003680) | 1.76552299 |
| 144 | Hypobetalipoproteinemia (HP:0003563) | 1.76260324 |
| 145 | Hypolipoproteinemia (HP:0010981) | 1.75906946 |
| 146 | Epileptic encephalopathy (HP:0200134) | 1.74888542 |
| 147 | Mitochondrial inheritance (HP:0001427) | 1.74082104 |
| 148 | Muscular dystrophy (HP:0003560) | 1.74052106 |
| 149 | Steppage gait (HP:0003376) | 1.73854177 |
| 150 | Postural instability (HP:0002172) | 1.70780991 |
| 151 | Proximal amyotrophy (HP:0007126) | 1.70517459 |
| 152 | Hyperglycemia (HP:0003074) | 1.68509429 |
| 153 | Difficulty climbing stairs (HP:0003551) | 1.66699423 |
| 154 | Abnormal finger flexion creases (HP:0006143) | 1.64036580 |
| 155 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.62435295 |
| 156 | Dialeptic seizures (HP:0011146) | 1.60019813 |
| 157 | Limb dystonia (HP:0002451) | 1.59690223 |
| 158 | Pheochromocytoma (HP:0002666) | 1.58486680 |
| 159 | Hip contracture (HP:0003273) | 1.56355585 |
| 160 | Progressive cerebellar ataxia (HP:0002073) | 1.55480673 |
| 161 | Abnormality of potassium homeostasis (HP:0011042) | 1.55458702 |
| 162 | Ragged-red muscle fibers (HP:0003200) | 1.54157543 |
| 163 | Scanning speech (HP:0002168) | 1.52807858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 3.81113098 |
| 2 | BCKDK | 3.31403462 |
| 3 | OBSCN | 3.14446081 |
| 4 | BRSK2 | 2.92367418 |
| 5 | MARK1 | 2.87423076 |
| 6 | RIPK1 | 2.66867272 |
| 7 | EPHB1 | 2.56257521 |
| 8 | WNK4 | 2.45148069 |
| 9 | OXSR1 | 2.42051071 |
| 10 | PHKG2 | 2.40585178 |
| 11 | PHKG1 | 2.40585178 |
| 12 | CASK | 2.33537822 |
| 13 | TTN | 2.32875142 |
| 14 | MAP2K3 | 2.12720804 |
| 15 | NTRK2 | 1.90314888 |
| 16 | MUSK | 1.89819495 |
| 17 | TGFBR2 | 1.88158013 |
| 18 | GRK7 | 1.86340694 |
| 19 | UHMK1 | 1.85526675 |
| 20 | NTRK3 | 1.76361186 |
| 21 | PIK3CG | 1.75526090 |
| 22 | MAP4K1 | 1.72144505 |
| 23 | MAPKAPK5 | 1.69820700 |
| 24 | MAP3K14 | 1.69414544 |
| 25 | PIK3CA | 1.63510008 |
| 26 | MST4 | 1.57219699 |
| 27 | PINK1 | 1.50048236 |
| 28 | MYLK | 1.44995949 |
| 29 | MAP2K4 | 1.43977879 |
| 30 | TRPM7 | 1.43234858 |
| 31 | PDK2 | 1.38176938 |
| 32 | STK24 | 1.36899715 |
| 33 | MAP2K6 | 1.33213044 |
| 34 | PKN1 | 1.31477461 |
| 35 | WNK1 | 1.31087850 |
| 36 | MAP3K6 | 1.30272683 |
| 37 | MAP3K3 | 1.26618841 |
| 38 | MAP3K7 | 1.24454364 |
| 39 | PDK3 | 1.21874649 |
| 40 | PDK4 | 1.21874649 |
| 41 | EPHA4 | 1.21836235 |
| 42 | CAMKK2 | 1.18151891 |
| 43 | SGK2 | 1.16800960 |
| 44 | MAPK12 | 1.15123839 |
| 45 | CSF1R | 1.14798131 |
| 46 | EPHA3 | 1.10672548 |
| 47 | DAPK2 | 1.10189254 |
| 48 | BRSK1 | 1.05442461 |
| 49 | WEE1 | 1.05316210 |
| 50 | PAK6 | 1.04925347 |
| 51 | TBK1 | 1.02762163 |
| 52 | KIT | 1.01825147 |
| 53 | ZAP70 | 1.01341321 |
| 54 | NME1 | 0.99129854 |
| 55 | TNIK | 0.99052539 |
| 56 | MAPK15 | 0.98302908 |
| 57 | PRKCQ | 0.97071143 |
| 58 | BLK | 0.96971130 |
| 59 | CAMK2D | 0.96622994 |
| 60 | IKBKE | 0.94073171 |
| 61 | MAP3K9 | 0.93796685 |
| 62 | MAP3K13 | 0.93794820 |
| 63 | CAMK1 | 0.89782992 |
| 64 | FGFR4 | 0.88276486 |
| 65 | TXK | 0.87531326 |
| 66 | PRKAA1 | 0.85929439 |
| 67 | CAMKK1 | 0.85924457 |
| 68 | CDK5 | 0.85097301 |
| 69 | DMPK | 0.84842463 |
| 70 | LMTK2 | 0.84384472 |
| 71 | CAMK2G | 0.82984710 |
| 72 | SGK3 | 0.81841953 |
| 73 | TIE1 | 0.81599763 |
| 74 | PRKG1 | 0.79755497 |
| 75 | ITK | 0.78438709 |
| 76 | ACVR1B | 0.77249835 |
| 77 | STK11 | 0.77102084 |
| 78 | ERN1 | 0.77047249 |
| 79 | SGK494 | 0.75460925 |
| 80 | SGK223 | 0.75460925 |
| 81 | FGFR2 | 0.75429061 |
| 82 | MAPK7 | 0.74738701 |
| 83 | CAMK4 | 0.74342488 |
| 84 | INSRR | 0.73168327 |
| 85 | TYK2 | 0.73018206 |
| 86 | MAPK13 | 0.70564677 |
| 87 | PDK1 | 0.68390222 |
| 88 | SGK1 | 0.67855735 |
| 89 | BTK | 0.66485095 |
| 90 | PRKD1 | 0.63438565 |
| 91 | IKBKB | 0.63163828 |
| 92 | PKN2 | 0.61739348 |
| 93 | JAK1 | 0.61476563 |
| 94 | ROCK1 | 0.61309063 |
| 95 | BMPR1B | 0.60012150 |
| 96 | FRK | 0.59953479 |
| 97 | CAMK2B | 0.59763652 |
| 98 | TEC | 0.59309188 |
| 99 | PDPK1 | 0.58552749 |
| 100 | PRKAA2 | 0.58483361 |
| 101 | RET | 0.57758460 |
| 102 | MAPK4 | 0.56469509 |
| 103 | ARAF | 0.55432130 |
| 104 | MATK | 0.55031026 |
| 105 | PRKD3 | 0.54556205 |
| 106 | NEK9 | 0.54171339 |
| 107 | SYK | 0.52504235 |
| 108 | LATS2 | 0.52335400 |
| 109 | ROCK2 | 0.52265807 |
| 110 | NEK6 | 0.51768530 |
| 111 | TAOK1 | 0.51702847 |
| 112 | MAP2K2 | 0.50943340 |
| 113 | MAP2K7 | 0.50767900 |
| 114 | PNCK | 0.50570146 |
| 115 | PRKACA | 0.50461710 |
| 116 | MET | 0.49841405 |
| 117 | MST1R | 0.49613201 |
| 118 | PAK3 | 0.49443456 |
| 119 | FGR | 0.48648846 |
| 120 | JAK2 | 0.48247166 |
| 121 | RPS6KA3 | 0.48186082 |
| 122 | MARK2 | 0.48035600 |
| 123 | MAPK10 | 0.47981338 |
| 124 | BCR | 0.47635756 |
| 125 | CSNK1G3 | 0.47607408 |
| 126 | LCK | 0.47599957 |
| 127 | CAMK2A | 0.47247432 |
| 128 | PRKACB | 0.47160756 |
| 129 | MAP3K1 | 0.47051421 |
| 130 | FLT3 | 0.46610464 |
| 131 | HIPK2 | 0.46427352 |
| 132 | IRAK4 | 0.46273214 |
| 133 | PRKCE | 0.45799319 |
| 134 | MAP3K12 | 0.44384561 |
| 135 | PRKCG | 0.44323115 |
| 136 | BMPR2 | 0.43697487 |
| 137 | CSNK1A1L | 0.43542234 |
| 138 | STK38 | 0.43074606 |
| 139 | FER | 0.43070269 |
| 140 | AKT3 | 0.42730110 |
| 141 | MAP3K2 | 0.41053028 |
| 142 | MAP3K5 | 0.40238332 |
| 143 | KSR2 | 0.40133998 |
| 144 | MAPKAPK3 | 0.39949039 |
| 145 | CSNK1G1 | 0.39880192 |
| 146 | PRKCH | 0.38877037 |
| 147 | SIK1 | 0.37957620 |
| 148 | GRK5 | 0.37292611 |
| 149 | NLK | 0.36729935 |
| 150 | MAP2K1 | 0.35585917 |
| 151 | PRKACG | 0.34363356 |
| 152 | MAP3K10 | 0.33747443 |
| 153 | DYRK1A | 0.32430825 |
| 154 | FGFR3 | 0.32026824 |
| 155 | PRKCA | 0.29859753 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.06803642 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.90306705 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.75543550 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.56729838 |
| 5 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44524733 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36251831 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.28086800 |
| 8 | Histidine metabolism_Homo sapiens_hsa00340 | 2.26049277 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.14537072 |
| 10 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.02889431 |
| 11 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.93015577 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.91432571 |
| 13 | Circadian rhythm_Homo sapiens_hsa04710 | 1.89315990 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.87509616 |
| 15 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82916915 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.78934860 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.77433678 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77400795 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.77383016 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.77333693 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.75925258 |
| 22 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.75590106 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.75363622 |
| 24 | Circadian entrainment_Homo sapiens_hsa04713 | 1.73223947 |
| 25 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.70807306 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70444251 |
| 27 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.70242259 |
| 28 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.61357660 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.60040952 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.59277399 |
| 31 | Long-term potentiation_Homo sapiens_hsa04720 | 1.58690269 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.53857899 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.52428290 |
| 34 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.50484413 |
| 35 | Nicotine addiction_Homo sapiens_hsa05033 | 1.49906364 |
| 36 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.48329797 |
| 37 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.48175348 |
| 38 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.44190788 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.43446231 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39510115 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.38413110 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37169778 |
| 43 | Parkinsons disease_Homo sapiens_hsa05012 | 1.34555012 |
| 44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.34368439 |
| 45 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.31699117 |
| 46 | Morphine addiction_Homo sapiens_hsa05032 | 1.31489857 |
| 47 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.31229252 |
| 48 | GABAergic synapse_Homo sapiens_hsa04727 | 1.28505775 |
| 49 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.27510112 |
| 50 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.27387347 |
| 51 | Salivary secretion_Homo sapiens_hsa04970 | 1.25462891 |
| 52 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.25398086 |
| 53 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.22636643 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21355395 |
| 55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.21237972 |
| 56 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.20604902 |
| 57 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.19351999 |
| 58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.15831126 |
| 59 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.11865735 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 1.11523403 |
| 61 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.10757582 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.09400835 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09219317 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.05789139 |
| 65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.05413200 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.04523469 |
| 67 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01416329 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00463329 |
| 69 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.00248834 |
| 70 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.99902533 |
| 71 | Long-term depression_Homo sapiens_hsa04730 | 0.99663853 |
| 72 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.98354995 |
| 73 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96175566 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.95585668 |
| 75 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.95387156 |
| 76 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.95286560 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.93836386 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.93271810 |
| 79 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.91445218 |
| 80 | Cocaine addiction_Homo sapiens_hsa05030 | 0.90632494 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89504894 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 0.89407141 |
| 83 | Bile secretion_Homo sapiens_hsa04976 | 0.87243527 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.85328964 |
| 85 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.85067462 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.84293377 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82692633 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.82613420 |
| 89 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.81202720 |
| 90 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80533412 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.79849312 |
| 92 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.77447196 |
| 93 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.77259384 |
| 94 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.75799324 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.74923338 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74691444 |
| 97 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74331764 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.72520675 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69840268 |
| 100 | Taste transduction_Homo sapiens_hsa04742 | 0.65112758 |
| 101 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64543450 |
| 102 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63748986 |
| 103 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.63217025 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61910375 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.61847627 |
| 106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61620113 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58376655 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55618690 |
| 109 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55403978 |
| 110 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54543113 |
| 111 | Olfactory transduction_Homo sapiens_hsa04740 | 0.53109930 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52946683 |
| 113 | Tight junction_Homo sapiens_hsa04530 | 0.52485346 |
| 114 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52154995 |
| 115 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.51269488 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51251151 |
| 117 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50633215 |
| 118 | Gap junction_Homo sapiens_hsa04540 | 0.50437961 |
| 119 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49032555 |
| 120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47677248 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.47508202 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47191006 |
| 123 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46278448 |
| 124 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.45104500 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44422956 |
| 126 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.42921703 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42051655 |
| 128 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41056123 |
| 129 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.41052845 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.37410839 |
| 131 | Huntingtons disease_Homo sapiens_hsa05016 | 0.37312640 |
| 132 | Lysosome_Homo sapiens_hsa04142 | 0.35202739 |
| 133 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35045556 |
| 134 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34805524 |
| 135 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32981098 |
| 136 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.31848308 |
| 137 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.31738520 |
| 138 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.30888187 |
| 139 | Pertussis_Homo sapiens_hsa05133 | 0.30733121 |
| 140 | Protein export_Homo sapiens_hsa03060 | 0.30079516 |
| 141 | Viral myocarditis_Homo sapiens_hsa05416 | 0.29330553 |
| 142 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.27470093 |
| 143 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.26006635 |
| 144 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.25392627 |
| 145 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24981679 |
| 146 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.20778024 |
| 147 | Leishmaniasis_Homo sapiens_hsa05140 | 0.20505319 |
| 148 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.19735400 |
| 149 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.18923540 |
| 150 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.17465377 |
| 151 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.15979481 |
| 152 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.15620326 |
| 153 | Amoebiasis_Homo sapiens_hsa05146 | 0.15469267 |
| 154 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.14836761 |

